Back to Newsroom

Corbus Pharmaceuticals Announces Initiation of Trading on The Nasdaq Capital Market

NORWOOD, MA–(Marketwired – Apr 16, 2015) –Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), a clinical stage drug development company focused on the development and commercialization of treatments for rare, life-threatening inflammatory and fibrotic diseases, announced that its common stock will begin trading today on The Nasdaq Capital Market (NASDAQ) under the current ticker symbol, CRBP.

Click here to read more